Cite
HARVARD Citation
Shimomura, A. et al. (2021). Corrigendum to: A randomized phase III study comparing trastuzumab emtansine with trastuzumab, pertuzumab and docetaxel in elderly patients with advanced stage HER2-positive breast cancer: Japan Clinical Oncology Group Study (JCOG1607, HERB TEA study). Japanese journal of clinical oncology. p. 1479. [Online].